DE3324626A1 - Lagerstabiles universalkontrollserum - Google Patents

Lagerstabiles universalkontrollserum

Info

Publication number
DE3324626A1
DE3324626A1 DE19833324626 DE3324626A DE3324626A1 DE 3324626 A1 DE3324626 A1 DE 3324626A1 DE 19833324626 DE19833324626 DE 19833324626 DE 3324626 A DE3324626 A DE 3324626A DE 3324626 A1 DE3324626 A1 DE 3324626A1
Authority
DE
Germany
Prior art keywords
buffer
universal control
control serum
serum
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19833324626
Other languages
German (de)
English (en)
Inventor
Knut Dr.rer.nat. 8121 Wilzhofen Bartl
Rudolf Dr.rer.nat. 8132 Tutzing Portenhauser
Helmut Dr.Phil.Nat. 8120 Weilheim Rehner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Priority to DE19833324626 priority Critical patent/DE3324626A1/de
Priority to EP84107598A priority patent/EP0131826B1/de
Priority to AT84107598T priority patent/ATE30966T1/de
Priority to DE8484107598T priority patent/DE3467626D1/de
Priority to JP59139260A priority patent/JPS6038657A/ja
Publication of DE3324626A1 publication Critical patent/DE3324626A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/05—Reference solutions for assays of biological material containing blood cells or plasma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/80—Multi-analyte reference solutions containing cholesterol, glucose and the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE19833324626 1983-07-08 1983-07-08 Lagerstabiles universalkontrollserum Withdrawn DE3324626A1 (de)

Priority Applications (5)

Application Number Priority Date Filing Date Title
DE19833324626 DE3324626A1 (de) 1983-07-08 1983-07-08 Lagerstabiles universalkontrollserum
EP84107598A EP0131826B1 (de) 1983-07-08 1984-06-30 Lagerstabiles Universalkontrollserum
AT84107598T ATE30966T1 (de) 1983-07-08 1984-06-30 Lagerstabiles universalkontrollserum.
DE8484107598T DE3467626D1 (en) 1983-07-08 1984-06-30 Storage-stable universal control serum
JP59139260A JPS6038657A (ja) 1983-07-08 1984-07-06 貯蔵安定なユニバーサル対照血清

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833324626 DE3324626A1 (de) 1983-07-08 1983-07-08 Lagerstabiles universalkontrollserum

Publications (1)

Publication Number Publication Date
DE3324626A1 true DE3324626A1 (de) 1985-01-17

Family

ID=6203451

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19833324626 Withdrawn DE3324626A1 (de) 1983-07-08 1983-07-08 Lagerstabiles universalkontrollserum
DE8484107598T Expired DE3467626D1 (en) 1983-07-08 1984-06-30 Storage-stable universal control serum

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE8484107598T Expired DE3467626D1 (en) 1983-07-08 1984-06-30 Storage-stable universal control serum

Country Status (4)

Country Link
EP (1) EP0131826B1 (https=)
JP (1) JPS6038657A (https=)
AT (1) ATE30966T1 (https=)
DE (2) DE3324626A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0301554A1 (de) * 1987-07-31 1989-02-01 Roche Diagnostics GmbH Verfahren zur Beseitigung von unspezifischen Trübungen

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623628B1 (fr) * 1987-11-20 1990-04-20 Bio France Reactifs Serum etalon, de nature humaine, reconstitue a partir des fractions rejetees (non utilisees en therapeutique), du fractionnement du plasma humain, du sang humain, du sang placentaire ou retroplacentaire
DE4135404A1 (de) * 1991-10-26 1993-04-29 Boehringer Mannheim Gmbh Stabiles fluessiges kontroll- bzw. eichserum fuer die klinische diagnostik
EP1435241A1 (en) * 2002-12-30 2004-07-07 Kyokuto Pharmaceutical Industrial Co. Ltd Method for stabilizing blood, serum, or plasma specimen and container containing ph buffer agent
WO2006054519A1 (ja) * 2004-11-17 2006-05-26 Kyowa Medex Co., Ltd. リポ蛋白中成分の分別定量用標準品

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3728226A (en) * 1970-06-01 1973-04-17 Baxter Laboratories Inc Blood serum analytical control standard
DE2617742A1 (de) * 1974-12-31 1977-06-30 Behringwerke Ag Stabiles blutplasma, verfahren zu dessen herstellung und seine verwendung als vergleichsplasma bei gerinnungs-untersuchungen
US4271122A (en) * 1978-04-27 1981-06-02 Hoffmann-La Roche Inc. Control plasma
US4264471A (en) * 1979-06-04 1981-04-28 E. I. Du Pont De Nemours And Company Serum and plasma clarification process
US4438202A (en) * 1981-11-30 1984-03-20 Technicon Instruments Corporation Stable, base serum compositions and preparation thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0301554A1 (de) * 1987-07-31 1989-02-01 Roche Diagnostics GmbH Verfahren zur Beseitigung von unspezifischen Trübungen

Also Published As

Publication number Publication date
JPS6038657A (ja) 1985-02-28
EP0131826A1 (de) 1985-01-23
JPH0316621B2 (https=) 1991-03-06
DE3467626D1 (en) 1987-12-23
ATE30966T1 (de) 1987-12-15
EP0131826B1 (de) 1987-11-19

Similar Documents

Publication Publication Date Title
Schaper et al. Ultrastructural morphometric analysis of myocardium from dogs, rats, hamsters, mice, and from human hearts.
DE69917403T2 (de) Glukose-sensor
DE3024044A1 (de) Verfahren zur kalibrierung oder qualitaetskontrolle von instrumenten und bezugsfluessigkeit
DE69619982T2 (de) Stabilisierte standards und kalibratoren
DE69527366T2 (de) Enzymatische zusammensetzung fur die klinische untersuchung
EP0222380B1 (de) Verfahren zur Stabilisierung von Creatinkinase
DE69015119T2 (de) Stabilisierte Enzym-Mischungen.
DE19708173A1 (de) Zellvolumenregulierte humane Kinase h-sgk
DE69319693T2 (de) Formulierung zur Stabilisierung der enzymatischen Aktivität und immunreaktivität von Creatinkinase und Creatinkinase-Isoenzymen
DE2928880C2 (de) Bilirubin-Standard-Zubereitung mit verbesserter Stabilität
DE3324626A1 (de) Lagerstabiles universalkontrollserum
EP0942284B1 (de) Gebrauchsfertiges Prothrombinzeitreagenz auf der Basis von rekombinantem Gewebsfaktor
DE3227912A1 (de) Stabilisierte zwischenmetabolite und verfahren zur herstellung
DE69326989T2 (de) Stabiles, einzelnes Flüssigreagens zur Bestimmung von Kohlendioxid im Serum
DE3129029A1 (de) Kompensierte referenzfluessigkeit zur verwendung in einem chemischen analysegeraet
DE68921261T2 (de) Auf menschlichem Serum basierende stabile Kontrolle.
DE68908764T2 (de) Pufferlösungssysteme und Elektrolyten zur Eichung von Analysegeräten.
DE1448101A1 (de) Verwendung eines Glases fuer Glaselektroden
EP0007057B1 (de) Kontrollserum für die klinisch-chemische Analyse mit einem bestimmten Gehalt an Creatin-kinase
DE2050267C3 (de) Verfahren zur Herstellung von stabilen Zubereitungen von reduziertem Nicotinamidadenindinucleotid
DE69817449T2 (de) Verfahren und Reagenz zur Bestimmung von direktem Bilirubin
DD149421A5 (de) Verfahren und reagenz zur bestimmung der creatinkinase mb
DE2642855A1 (de) Differentielle bestimmung von creatin-phosphokinase-isoenzymen
DE69227346T2 (de) Stabilisierte Kontroll- oder Kalibrierungsflüssigkeit für Kreatinkinase
DE3641489C2 (https=)

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee